HepG2 cells stimulated by THP-1-conditioned medium: a potential in vitro model of systemic inflammation–induced hepatic alterations
Veronika Vyletelová, Marek Bohunčák, Jana Hricovíniová, Gabriela Greifová, Peter Vavrinec, Jakub Krivý, Dimitris Kardassis, Ľudmila Pašková

TL;DR
This study creates an in vitro model using HepG2 cells and THP-1-conditioned medium to study how systemic inflammation affects liver metabolism and lipoprotein changes.
Contribution
A novel in vitro model is developed to study inflammation-induced hepatic metabolic changes under conditions mimicking systemic inflammation.
Findings
Short-term exposure to THP-1-conditioned medium altered inflammatory gene and transcription factor mRNA expression in HepG2 cells.
Lipoprotein-associated gene expression was significantly modified at different time points following exposure.
The model showed no effect on HepG2 cell viability after 24 hours of exposure.
Abstract
Chronic inflammatory diseases are associated with qualitative and quantitative changes in lipid and lipoprotein metabolism, including high density lipoproteins (HDLs), increasing patients´ susceptibility to atherosclerosis and cardiovascular mortality. Given the liver’s central role in lipoprotein metabolism and systemic inflammation, we aimed to develop and investigate an in vitro model of inflammation-induced hepatic metabolic changes. To better approximate in vivo conditions, where systemic inflammation exposes the liver to a complex environment rich in cytokines and inflammatory mediators, we exposed human hepatocarcinoma HepG2 cells to conditioned media (CM) from THP-1-derived macrophages using phorbol-12-myristate-13-acetate (PMA) and lipopolysaccharide (LPS). The effect of CM on mRNA expression in HepG2 was tested by quantitative real-time PCR or protein expression by Western…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver physiology and pathology · Drug Transport and Resistance Mechanisms · Liver Disease Diagnosis and Treatment
